Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer

Carcinogenesis - Tập 34 Số 1 - Trang 10-19 - 2013
Jingsong Chen1, Xiaohui Huang, Qian Wang, Huang Jing, Longjuan Zhang, Xilin Chen, Jian Lei, Zhixiang Cheng
1Department of General Surgery, the First Affiliated Hospital of Guangzhou Medical College, Guangzhou 510120, P.R. China.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Llovet, 2003, Hepatocellular carcinoma., Lancet, 362, 1907, 10.1016/S0140-6736(03)14964-1

Rubin, 2006, Targeting the Hedgehog pathway in cancer., Nat. Rev. Drug Discov., 5, 1026, 10.1038/nrd2086

Katoh, 2006, Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review)., Int. J. Mol. Med., 18, 1019

Ruiz i Altaba, 2002, Gli and hedgehog in cancer: tumours, embryos and stem cells, Nat. Rev. Cancer, 2, 361, 10.1038/nrc796

Pasca di Magliano, 2003, Hedgehog signalling in cancer formation and maintenance, Nat. Rev. Cancer, 3, 903, 10.1038/nrc1229

Thayer, 2003, Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis., Nature, 425, 851, 10.1038/nature02009

Evangelista, 2006, The hedgehog signaling pathway in cancer, Clin. Cancer Res., 12, 5924, 10.1158/1078-0432.CCR-06-1736

Yang, 2010, Activation of the hedgehog-signaling pathway in human cancer and the clinical implications., Oncogene, 29, 469, 10.1038/onc.2009.392

Sicklick, 2006, Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis., Carcinogenesis, 27, 748, 10.1093/carcin/bgi292

Patil, 2006, Hedgehog signaling in human hepatocellular carcinoma., Cancer Biol. Ther ., 5, 111, 10.4161/cbt.5.1.2379

Huang, 2006, Activation of the hedgehog pathway in human hepatocellular carcinomas., Carcinogenesis, 27, 1334, 10.1093/carcin/bgi378

Karhadkar, 2004, Hedgehog signalling in prostate regeneration, neoplasia and metastasis., Nature, 431, 707, 10.1038/nature02962

Yoo, 2008, Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway., Carcinogenesis, 29, 480, 10.1093/carcin/bgm281

Mori, 2006, Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma., Oncology, 70, 378, 10.1159/000098111

Feldmann, 2007, Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers., Cancer Res ., 67, 2187, 10.1158/0008-5472.CAN-06-3281

Nagai, 2008, Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation., Cancer Sci ., 99, 1377, 10.1111/j.1349-7006.2008.00822.x

Liao, 2009, Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation., Carcinogenesis, 30, 131, 10.1093/carcin/bgn230

Vihinen, 2005, Matrix metalloproteinases as therapeutic targets in cancer., Curr. Cancer Drug Targets, 5, 203, 10.2174/1568009053765799

Freije, 2003, Matrix metalloproteinases and tumor progression., Adv. Exp. Med. Biol., 532, 91, 10.1007/978-1-4615-0081-0_9

Chen, 2009, Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9., Hepatol. Res., 39, 177, 10.1111/j.1872-034X.2008.00449.x

Chen, 2010, FAK is involved in invasion and metastasis of hepatocellular carcinoma., Clin. Exp. Metastasis, 27, 71, 10.1007/s10585-010-9306-3

Chen, 1994, Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase., Proc. Natl. Acad. Sci. U.S.A ., 91, 10148, 10.1073/pnas.91.21.10148

Xia, 2004, Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway., J. Biol. Chem., 279, 33024, 10.1074/jbc.M313265200

Reif, 2003, The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression., J. Biol. Chem ., 278, 8083, 10.1074/jbc.M212927200

Tokunaga, 2008, Deregulation of the Akt pathway in human cancer., Curr. Cancer Drug Targets, 8, 27, 10.2174/156800908783497140

Cheng, 2006, Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway., Oncogene, 25, 7009, 10.1038/sj.onc.1209706

Chung, 2004, Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential., FASEB J., 18, 1123, 10.1096/fj.03-1429fje

Park, 2006, Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways., Cancer Res ., 66, 8511, 10.1158/0008-5472.CAN-05-4340

Huang, 2011, miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened., J. Pathol ., 225, 463, 10.1002/path.2877

Vihinen, 2002, Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets., Int. J. Cancer, 99, 157, 10.1002/ijc.10329

Bode, 1999, Insights into MMP-TIMP interactions., Ann. N. Y. Acad. Sci ., 878, 73, 10.1111/j.1749-6632.1999.tb07675.x

Tian, 2010, PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway., Oncol. Rep., 23, 1593

Elia, 2007, Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways., Biochim. Biophys. Acta, 1773, 1438, 10.1016/j.bbamcr.2007.06.006

Riobó, 2006, Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling., Proc. Natl. Acad. Sci. U.S.A., 103, 4505, 10.1073/pnas.0504337103

Schaller, 2001, Biochemical signals and biological responses elicited by the focal adhesion kinase., Biochim. Biophys. Acta, 1540, 1, 10.1016/S0167-4889(01)00123-9

Schlaepfer, 1999, Signaling through focal adhesion kinase., Prog. Biophys. Mol. Biol ., 71, 435, 10.1016/S0079-6107(98)00052-2

Xie, 2008, Hedgehog signaling pathway: development of antagonists for cancer therapy., Curr. Oncol. Rep., 10, 107, 10.1007/s11912-008-0018-7

Deutsch, 2001, A bipotential precursor population for pancreas and liver within the embryonic endoderm., Development, 128, 871, 10.1242/dev.128.6.871

Giannelli, 2002, Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma., Int. J. Cancer, 97, 425, 10.1002/ijc.1635

Arii, 1996, Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential., Hepatology, 24, 316, 10.1002/hep.510240206

Hayasaka, 1996, Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma., Hepatology, 24, 1058, 10.1002/hep.510240513

Bussink, 2008, Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer., Lancet Oncol., 9, 288, 10.1016/S1470-2045(08)70073-1

Fang, 2007, PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis., Cell. Signal ., 19, 2487, 10.1016/j.cellsig.2007.07.025

Yoo, 2011, Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer., Cancer Res ., 71, 7061, 10.1158/0008-5472.CAN-11-1338

Han, 2007, Role of focal adhesion kinase in human cancer: a potential target for drug discovery., Anticancer. Agents Med. Chem ., 7, 681, 10.2174/187152007784111296

McLean, 2005, The role of focal-adhesion kinase in cancer—a new therapeutic opportunity., Nat. Rev. Cancer, 5, 505, 10.1038/nrc1647

Siesser, 2006, The signaling and biological implications of FAK overexpression in cancer., Clin. Cancer Res., 12, 3233, 10.1158/1078-0432.CCR-06-0456

McLean, 2003, Focal adhesion kinase as a potential target in oncology., Expert Opin. Pharmacother., 4, 227, 10.1517/14656566.4.2.227

van Nimwegen, 2007, Focal adhesion kinase: a potential target in cancer therapy., Biochem. Pharmacol ., 73, 597, 10.1016/j.bcp.2006.08.011